Mary Stenzel-Poore - Publications

Affiliations: 
Molecular Microbiology and Immunology Oregon Health and Science University, Portland, OR 

51 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Mavroudakis L, Stevens SL, Duncan KD, Stenzel-Poore MP, Laskin J, Lanekoff I. CpG preconditioning reduces accumulation of lysophosphatidylcholine in ischemic brain tissue after middle cerebral artery occlusion. Analytical and Bioanalytical Chemistry. PMID 33078250 DOI: 10.1007/s00216-020-02987-w  0.472
2018 Stevens SL, Liu T, Bahjat FR, Petyuk VA, Schepmoes AA, Sontag RL, Gritsenko MA, Wu C, Wang S, Shukla AK, Jacobs JM, Smith RD, Rodland KD, Alexander West G, Kohama SG, ... ... Stenzel-Poore MP, et al. Preconditioning in the Rhesus Macaque Induces a Proteomic Signature Following Cerebral Ischemia that Is Associated with Neuroprotection. Translational Stroke Research. PMID 30341719 DOI: 10.1007/S12975-018-0670-7  0.464
2017 Bosetti F, Koenig JI, Ayata C, Back SA, Becker K, Broderick JP, Carmichael ST, Cho S, Cipolla MJ, Corbett D, Corriveau RA, Cramer SC, Ferguson AR, Finklestein SP, Ford BD, ... ... Stenzel-Poore MP, et al. Translational Stroke Research: Vision and Opportunities. Stroke. PMID 28751554 DOI: 10.1161/Strokeaha.117.017112  0.366
2017 Choo MK, Sano Y, Kim C, Yasuda K, Li XD, Lin X, Stenzel-Poore M, Alexopoulou L, Ghosh S, Latz E, Rifkin IR, Chen ZJ, Stewart GC, Chong H, Park JM. TLR sensing of bacterial spore-associated RNA triggers host immune responses with detrimental effects. The Journal of Experimental Medicine. PMID 28400473 DOI: 10.1084/Jem.20161141  0.363
2017 Bahjat FR, Alexander West G, Kohama SG, Glynn C, Urbanski HF, Hobbs TR, Earl E, Stevens SL, Stenzel-Poore MP. Preclinical Development of a Prophylactic Neuroprotective Therapy for the Preventive Treatment of Anticipated Ischemia-Reperfusion Injury. Translational Stroke Research. PMID 28378315 DOI: 10.1007/S12975-017-0532-8  0.419
2016 Gesuete R, Stevens SL, Stenzel-Poore MP. Role of Circulating Immune Cells in Stroke and Preconditioning-Induced Protection. Acta Neurochirurgica. Supplement. 121: 39-44. PMID 26463920 DOI: 10.1007/978-3-319-18497-5_7  0.437
2015 Gesuete R, Christensen SN, Bahjat FR, Packard AE, Stevens SL, Liu M, Salazar AM, Stenzel-Poore MP. Cytosolic Receptor Melanoma Differentiation-Associated Protein 5 Mediates Preconditioning-Induced Neuroprotection Against Cerebral Ischemic Injury. Stroke; a Journal of Cerebral Circulation. PMID 26564103 DOI: 10.1161/STROKEAHA.115.010329  0.746
2014 Stevens SL, Vartanian KB, Stenzel-Poore MP. Reprogramming the response to stroke by preconditioning. Stroke; a Journal of Cerebral Circulation. 45: 2527-31. PMID 24938838 DOI: 10.1161/STROKEAHA.114.002879  0.326
2014 Gesuete R, Kohama SG, Stenzel-Poore MP. Toll-like receptors and ischemic brain injury. Journal of Neuropathology and Experimental Neurology. 73: 378-86. PMID 24709682 DOI: 10.1097/NEN.0000000000000068  0.43
2012 Urbanski HF, Kohama SG, West GA, Glynn C, Williams-Karnesky RL, Earl E, Neuringer MN, Renner L, Weiss A, Stenzel-Poore M, Bahjat FR. Changes in spontaneous activity assessed by accelerometry correlate with extent of cerebral ischemia-reperfusion injury in the nonhuman primate. Translational Stroke Research. 3: 442-51. PMID 23580904 DOI: 10.1007/S12975-012-0191-8  0.456
2012 Gesuete R, Packard AE, Vartanian KB, Conrad VK, Stevens SL, Bahjat FR, Yang T, Stenzel-Poore MP. Poly-ICLC preconditioning protects the blood-brain barrier against ischemic injury in vitro through type I interferon signaling. Journal of Neurochemistry. 123: 75-85. PMID 23050645 DOI: 10.1111/j.1471-4159.2012.07946.x  0.759
2012 Packard AE, Leung PY, Vartanian KB, Stevens SL, Bahjat FR, Stenzel-Poore MP. TLR9 bone marrow chimeric mice define a role for cerebral TNF in neuroprotection induced by CpG preconditioning. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 32: 2193-200. PMID 23010947 DOI: 10.1038/jcbfm.2012.140  0.744
2012 McDermott JE, Vartanian KB, Mitchell H, Stevens SL, Sanfilippo A, Stenzel-Poore MP. Identification and validation of Ifit1 as an important innate immune bottleneck. Plos One. 7: e36465. PMID 22745654 DOI: 10.1371/journal.pone.0036465  0.32
2012 Leung PY, Stevens SL, Packard AE, Lessov NS, Yang T, Conrad VK, van den Dungen NN, Simon RP, Stenzel-Poore MP. Toll-like receptor 7 preconditioning induces robust neuroprotection against stroke by a novel type I interferon-mediated mechanism. Stroke; a Journal of Cerebral Circulation. 43: 1383-9. PMID 22403050 DOI: 10.1161/STROKEAHA.111.641522  0.78
2012 Packard AE, Hedges JC, Bahjat FR, Stevens SL, Conlin MJ, Salazar AM, Stenzel-Poore MP. Poly-IC preconditioning protects against cerebral and renal ischemia-reperfusion injury. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 32: 242-7. PMID 22086194 DOI: 10.1038/jcbfm.2011.160  0.746
2011 Vartanian KB, Stevens SL, Marsh BJ, Williams-Karnesky R, Lessov NS, Stenzel-Poore MP. LPS preconditioning redirects TLR signaling following stroke: TRIF-IRF3 plays a seminal role in mediating tolerance to ischemic injury. Journal of Neuroinflammation. 8: 140. PMID 21999375 DOI: 10.1186/1742-2094-8-140  0.491
2011 Stevens SL, Leung PY, Vartanian KB, Gopalan B, Yang T, Simon RP, Stenzel-Poore MP. Multiple preconditioning paradigms converge on interferon regulatory factor-dependent signaling to promote tolerance to ischemic brain injury. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 8456-63. PMID 21653850 DOI: 10.1523/JNEUROSCI.0821-11.2011  0.555
2011 Bahjat FR, Williams-Karnesky RL, Kohama SG, West GA, Doyle KP, Spector MD, Hobbs TR, Stenzel-Poore MP. Proof of concept: pharmacological preconditioning with a Toll-like receptor agonist protects against cerebrovascular injury in a primate model of stroke. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 31: 1229-42. PMID 21285967 DOI: 10.1038/jcbfm.2011.6  0.478
2011 Giardino WJ, Pastor R, Anacker AM, Spangler E, Cote DM, Li J, Stenzel-Poore MP, Phillips TJ, Ryabinin AE. Dissection of corticotropin-releasing factor system involvement in locomotor sensitivity to methamphetamine. Genes, Brain, and Behavior. 10: 78-89. PMID 20731720 DOI: 10.1111/J.1601-183X.2010.00641.X  0.305
2010 Vartanian K, Stenzel-Poore M. Toll-like receptor tolerance as a mechanism for neuroprotection. Translational Stroke Research. 1: 252-260. PMID 21339866 DOI: 10.1007/s12975-010-0033-5  0.301
2010 Gresack JE, Risbrough VB, Scott CN, Coste S, Stenzel-Poore M, Geyer MA, Powell SB. Isolation rearing-induced deficits in contextual fear learning do not require CRF(2) receptors. Behavioural Brain Research. 209: 80-4. PMID 20097235 DOI: 10.1016/J.Bbr.2010.01.018  0.307
2009 Williams-Karnesky RL, Stenzel-Poore MP. Adenosine and stroke: maximizing the therapeutic potential of adenosine as a prophylactic and acute neuroprotectant. Current Neuropharmacology. 7: 217-27. PMID 20190963 DOI: 10.2174/157015909789152209  0.342
2009 Leung PY, Packard AE, Stenzel-Poore MP. It's all in the family: multiple Toll-like receptors offer promise as novel therapeutic targets for stroke neuroprotection. Future Neurology. 4: 201-208. PMID 19885374 DOI: 10.2217/14796708.4.2.201  0.758
2009 Marsh B, Stevens SL, Packard AE, Gopalan B, Hunter B, Leung PY, Harrington CA, Stenzel-Poore MP. Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: a critical role for IRF3. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 9839-49. PMID 19657036 DOI: 10.1523/Jneurosci.2496-09.2009  0.774
2009 West GA, Golshani KJ, Doyle KP, Lessov NS, Hobbs TR, Kohama SG, Pike MM, Kroenke CD, Grafe MR, Spector MD, Tobar ET, Simon RP, Stenzel-Poore MP. A new model of cortical stroke in the rhesus macaque. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 29: 1175-86. PMID 19384334 DOI: 10.1038/Jcbfm.2009.43  0.328
2009 Marsh BJ, Stevens SL, Hunter B, Stenzel-Poore MP. Inflammation and the emerging role of the toll-like receptor system in acute brain ischemia. Stroke; a Journal of Cerebral Circulation. 40: S34-7. PMID 19064776 DOI: 10.1161/STROKEAHA.108.534917  0.469
2009 Risbrough VB, Geyer MA, Hauger RL, Coste S, Stenzel-Poore M, Wurst W, Holsboer F. CRF1 and CRF2 receptors are required for potentiated startle to contextual but not discrete cues. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1494-503. PMID 19020499 DOI: 10.1038/Npp.2008.205  0.373
2009 Marsh BJ, Williams-Karnesky RL, Stenzel-Poore MP. Toll-like receptor signaling in endogenous neuroprotection and stroke. Neuroscience. 158: 1007-20. PMID 18809468 DOI: 10.1016/j.neuroscience.2008.07.067  0.395
2008 Doyle KP, Yang T, Lessov NS, Ciesielski TM, Stevens SL, Simon RP, King JS, Stenzel-Poore MP. Nasal administration of osteopontin peptide mimetics confers neuroprotection in stroke. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 28: 1235-48. PMID 18364727 DOI: 10.1038/jcbfm.2008.17  0.402
2008 Doyle KP, Simon RP, Stenzel-Poore MP. Mechanisms of ischemic brain damage. Neuropharmacology. 55: 310-8. PMID 18308346 DOI: 10.1016/j.neuropharm.2008.01.005  0.412
2008 Stevens SL, Ciesielski TM, Marsh BJ, Yang T, Homen DS, Boule JL, Lessov NS, Simon RP, Stenzel-Poore MP. Toll-like receptor 9: a new target of ischemic preconditioning in the brain. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 28: 1040-7. PMID 18183029 DOI: 10.1038/sj.jcbfm.9600606  0.562
2007 Hickey EJ, You X, Kaimaktchiev V, Stenzel-Poore M, Ungerleider RM. Lipopolysaccharide preconditioning induces robust protection against brain injury resulting from deep hypothermic circulatory arrest. The Journal of Thoracic and Cardiovascular Surgery. 133: 1588-96. PMID 17532961 DOI: 10.1016/J.Jtcvs.2006.12.056  0.412
2007 Rosenzweig HL, Minami M, Lessov NS, Coste SC, Stevens SL, Henshall DC, Meller R, Simon RP, Stenzel-Poore MP. Endotoxin preconditioning protects against the cytotoxic effects of TNFalpha after stroke: a novel role for TNFalpha in LPS-ischemic tolerance. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 27: 1663-74. PMID 17327883 DOI: 10.1038/sj.jcbfm.9600464  0.498
2007 Stenzel-Poore MP, Stevens SL, King JS, Simon RP. Preconditioning reprograms the response to ischemic injury and primes the emergence of unique endogenous neuroprotective phenotypes: a speculative synthesis. Stroke; a Journal of Cerebral Circulation. 38: 680-5. PMID 17261715 DOI: 10.1161/01.STR.0000251444.56487.4c  0.366
2007 Harrington CA, Stevens S, Stenzel-Poore M, Simon RP. Gene expression profiling in ischemic brain injury and ischemic tolerance Handbook of Neurochemistry and Molecular Neurobiology: Acute Ischemic Injury and Repair in the Nervous System. 1-17. DOI: 10.1007/978-0-387-30383-3_1  0.397
2006 Stevens SL, Stenzel-Poore MP. Toll-like receptors and tolerance to ischaemic injury in the brain. Biochemical Society Transactions. 34: 1352-5. PMID 17073817 DOI: 10.1042/Bst0341352  0.473
2006 Coste SC, Heard AD, Phillips TJ, Stenzel-Poore MP. Corticotropin-releasing factor receptor type 2-deficient mice display impaired coping behaviors during stress. Genes, Brain, and Behavior. 5: 131-8. PMID 16507004 DOI: 10.1111/J.1601-183X.2005.00142.X  0.329
2005 Meller R, Stevens SL, Minami M, Cameron JA, King S, Rosenzweig H, Doyle K, Lessov NS, Simon RP, Stenzel-Poore MP. Neuroprotection by osteopontin in stroke. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 25: 217-25. PMID 15678124 DOI: 10.1038/Sj.Jcbfm.9600022  0.383
2004 Stenzel-Poore MP, Stevens SL, Simon RP. Genomics of preconditioning. Stroke; a Journal of Cerebral Circulation. 35: 2683-6. PMID 15459430 DOI: 10.1161/01.STR.0000143735.89281.bb  0.421
2004 Rosenzweig HL, Lessov NS, Henshall DC, Minami M, Simon RP, Stenzel-Poore MP. Endotoxin preconditioning prevents cellular inflammatory response during ischemic neuroprotection in mice. Stroke; a Journal of Cerebral Circulation. 35: 2576-81. PMID 15375302 DOI: 10.1161/01.STR.0000143450.04438.ae  0.474
2003 Stevens SL, Shaw TE, Dykhuizen E, Lessov NS, Hill JK, Wurst W, Stenzel-Poore MP. Reduced cerebral injury in CRH-R1 deficient mice after focal ischemia: a potential link to microglia and atrocytes that express CRH-R1. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 23: 1151-9. PMID 14526225 DOI: 10.1097/01.Wcb.0000086957.72078.D4  0.435
2003 Stenzel-Poore MP, Stevens SL, Xiong Z, Lessov NS, Harrington CA, Mori M, Meller R, Rosenzweig HL, Tobar E, Shaw TE, Chu X, Simon RP. Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet (London, England). 362: 1028-37. PMID 14522533 DOI: 10.1016/S0140-6736(03)14412-1  0.367
2001 Preil J, Müller MB, Gesing A, Reul JM, Sillaber I, van Gaalen MM, Landgrebe J, Holsboer F, Stenzel-Poore M, Wurst W. Regulation of the hypothalamic-pituitary-adrenocortical system in mice deficient for CRH receptors 1 and 2. Endocrinology. 142: 4946-55. PMID 11606463 DOI: 10.1210/Endo.142.11.8507  0.379
2000 Clark WM, Rinker LG, Lessov NS, Hazel K, Hill JK, Stenzel-Poore M, Eckenstein F. Lack of interleukin-6 expression is not protective against focal central nervous system ischemia. Stroke; a Journal of Cerebral Circulation. 31: 1715-20. PMID 10884478 DOI: 10.1161/01.Str.31.7.1715  0.328
1999 Hill JK, Gunion-Rinker L, Kulhanek D, Lessov N, Kim S, Clark WM, Dixon MP, Nishi R, Stenzel-Poore MP, Eckenstein FP. Temporal modulation of cytokine expression following focal cerebral ischemia in mice. Brain Research. 820: 45-54. PMID 10023029 DOI: 10.1016/S0006-8993(98)01140-8  0.332
1996 Heinrichs SC, Stenzel-Poore MP, Gold LH, Battenberg E, Bloom FE, Koob GF, Vale WW, Pich EM. Learning impairment in transgenic mice with central overexpression of corticotropin-releasing factor. Neuroscience. 74: 303-11. PMID 8865183 DOI: 10.1016/0306-4522(96)00140-6  0.449
1996 Stenzel-Poore MP, Duncan JE, Rittenberg MB, Bakke AC, Heinrichs SC. CRH overproduction in transgenic mice: behavioral and immune system modulation. Annals of the New York Academy of Sciences. 780: 36-48. PMID 8602738 DOI: 10.1111/J.1749-6632.1996.Tb15110.X  0.316
1994 Stenzel-Poore MP, Heinrichs SC, Rivest S, Koob GF, Vale WW. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 2579-84. PMID 8182429 DOI: 10.1523/Jneurosci.14-05-02579.1994  0.386
1993 Stenzel-Poore M, Vale WW, Rivier C. Relationship between antigen-induced immune stimulation and activation of the hypothalamic-pituitary-adrenal axis in the rat. Endocrinology. 132: 1313-8. PMID 8382598 DOI: 10.1210/endo.132.3.8382598  0.358
1992 Stenzel-Poore MP, Cameron VA, Vaughan J, Sawchenko PE, Vale W. Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice. Endocrinology. 130: 3378-86. PMID 1597149 DOI: 10.1210/Endo.130.6.1597149  0.36
1992 Stenzel-Poore MP, Heldwein KA, Stenzel P, Lee S, Vale WW. Characterization of the genomic corticotropin-releasing factor (CRF) gene from Xenopus laevis: two members of the CRF family exist in amphibians. Molecular Endocrinology (Baltimore, Md.). 6: 1716-24. PMID 1448118 DOI: 10.1210/mend.6.10.1448118  0.351
Show low-probability matches.